CD69 and neoplasm: The fact that we did not observed an increase number of effector cells after 1,25(OH)2D3 exposure, but instead, and upregulation of the CD69 marker, possibly suggests that 1,25(OH)2D3 does not have the ability to increase the recruitment of immune cells to the tumor bed but it can enhance their activation.